Citation Impact
Citing Papers
TNF-α Promotes c-REL/ΔNp63α Interaction and TAp73 Dissociation from Key Genes That Mediate Growth Arrest and Apoptosis in Head and Neck Cancer
2011
DNA Damage–Specific Control of Cell Death by Cryptochrome in p53-Mutant Ras–Transformed Cells
2012 StandoutNobel
ΔNp63 Versatilely Regulates a Broad NF-κB Gene Program and Promotes Squamous Epithelial Proliferation, Migration, and Inflammation
2011
ΔNP63α Transcriptionally Activates Chemokine Receptor 4 (CXCR4) Expression to Regulate Breast Cancer Stem Cell Activity and Chemotaxis
2014
CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells
2011
Bcl-2 Blocks Cisplatin-Induced Apoptosis and Predicts Poor Outcome Following Chemoradiation Treatment in Advanced Oropharyngeal Squamous Cell Carcinoma
2009
Cysteine-rich 61-Connective Tissue Growth Factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced Signaling Protein-2 (WISP-2) Regulates MicroRNA-10b via Hypoxia-inducible Factor-1α-TWIST Signaling Networks in Human Breast Cancer Cells
2011
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
Triple-negative breast cancer molecular subtyping and treatment progress
2020 Standout
Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents
2012
Head and neck squamous cell carcinoma
2020 Standout
Combined modality therapy with TRAIL or agonistic death receptor antibodies
2011
Targeting Oncogenic Mutant p53 for Cancer Therapy
2015
Roles of individual prolyl‐4‐hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice
2012 StandoutNobel
Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma
2019 StandoutNobel
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?
2011
ROS Function in Redox Signaling and Oxidative Stress
2014 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
HPV-associated head and neck cancer: a virus-related cancer epidemic
2010 Standout
Gain of function of mutant p53 by coaggregation with multiple tumor suppressors
2011
Cellular Responses to Cisplatin‐Induced DNA Damage
2010
Targeting apoptosis in cancer therapy
2020 Standout
Molecular chaperones in protein folding and proteostasis
2011 StandoutNature
Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy
2016 Standout
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
2013 Standout
DNA Damage-Induced Primordial Follicle Oocyte Apoptosis and Loss of Fertility Require TAp63-Mediated Induction of Puma and Noxa
2012
Cisplatin: The first metal based anticancer drug
2019 Standout
Effects of Physiological Levels of the Green Tea Extract Epigallocatechin-3-Gallate on Breast Cancer Cells
2014
Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth
2015 Nature
树鼩——作为一种新颖的非人灵长类实验疾病动物模型
2017 Standout
Inhibition of Aβ25–35-induced cell apoptosis by Low-power-laser-irradiation (LPLI) through promoting Akt-dependent YAP cytoplasmic translocation
2011
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Hypoxia-inducible factor 1 and breast cancer metastasis
2015 StandoutNobel
The jury is in: p73 is a tumor suppressor after all: Figure 1.
2008
Triple-negative breast cancer—current status and future directions
2009
The first 30 years of p53: growing ever more complex
2009 Standout
A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry
2014 Standout
c-Abl phosphorylation of ΔNp63α is critical for cell viability
2010
Gallic acid: a versatile antioxidant with promising therapeutic and industrial applications
2015 Standout
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis
2010
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer
2015
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
Circadian Clock, Cancer, and Chemotherapy
2014 StandoutNobel
Effect of circadian clock mutations on DNA damage response in mammalian cells
2012 StandoutNobel
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
A tree shrew glioblastoma model recapitulates features of human glioblastoma
2017
Works of N. Vidnovic being referenced
Mutant p53 mediates survival of breast cancer cells
2009
Radioisotopic Localization of 90Yttrium–Ibritumomab Tiuxetan in Patients with CD20+ Non-Hodgkin’s Lymphoma
2008
The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers
2007
p63/p73 expression mediates cisplatin sensitivity in a subset of triple-negative primary breast cancer: Implications for a new clinical trial
2007